CN102114240B - 原料含有水蛭素、纤溶素的药物的用途 - Google Patents
原料含有水蛭素、纤溶素的药物的用途 Download PDFInfo
- Publication number
- CN102114240B CN102114240B CN 201110007679 CN201110007679A CN102114240B CN 102114240 B CN102114240 B CN 102114240B CN 201110007679 CN201110007679 CN 201110007679 CN 201110007679 A CN201110007679 A CN 201110007679A CN 102114240 B CN102114240 B CN 102114240B
- Authority
- CN
- China
- Prior art keywords
- amenorrhea
- hirudin
- medicine
- hyaluronidase
- enteric coated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 78
- 102000007625 Hirudins Human genes 0.000 title claims abstract description 53
- 108010007267 Hirudins Proteins 0.000 title claims abstract description 53
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 title claims abstract description 53
- 229940006607 hirudin Drugs 0.000 title claims abstract description 53
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 title abstract 3
- 201000000736 Amenorrhea Diseases 0.000 claims abstract description 60
- 206010001928 Amenorrhoea Diseases 0.000 claims abstract description 60
- 231100000540 amenorrhea Toxicity 0.000 claims abstract description 60
- 108010003272 Hyaluronate lyase Proteins 0.000 claims abstract description 49
- 102000001974 Hyaluronidases Human genes 0.000 claims abstract description 49
- 229960002773 hyaluronidase Drugs 0.000 claims abstract description 49
- 238000002360 preparation method Methods 0.000 claims abstract description 30
- 239000002994 raw material Substances 0.000 claims abstract description 24
- 230000001575 pathological effect Effects 0.000 claims abstract description 9
- 239000003527 fibrinolytic agent Substances 0.000 claims description 49
- 230000003480 fibrinolytic effect Effects 0.000 claims description 49
- 239000002775 capsule Substances 0.000 claims description 20
- 238000012360 testing method Methods 0.000 abstract description 27
- 241001465754 Metazoa Species 0.000 abstract description 6
- 230000002611 ovarian Effects 0.000 abstract description 4
- 230000000144 pharmacologic effect Effects 0.000 abstract description 3
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 8
- 210000001672 ovary Anatomy 0.000 description 8
- 229940079593 drug Drugs 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 229910021529 ammonia Inorganic materials 0.000 description 4
- 230000005906 menstruation Effects 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000004696 endometrium Anatomy 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000027758 ovulation cycle Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 206010021033 Hypomenorrhoea Diseases 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 238000010241 blood sampling Methods 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 210000004392 genitalia Anatomy 0.000 description 2
- 230000003054 hormonal effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 238000011121 vaginal smear Methods 0.000 description 2
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 1
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 1
- 206010020852 Hypertonia Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 102000009151 Luteinizing Hormone Human genes 0.000 description 1
- 108010073521 Luteinizing Hormone Proteins 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 102000003946 Prolactin Human genes 0.000 description 1
- 108010057464 Prolactin Proteins 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 239000009709 daotan Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000009261 endocrine therapy Methods 0.000 description 1
- 229940034984 endocrine therapy antineoplastic and immunomodulating agent Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 229940028334 follicle stimulating hormone Drugs 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 239000008616 guibi-tang Substances 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 230000002267 hypothalamic effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 230000009247 menarche Effects 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 238000011022 operating instruction Methods 0.000 description 1
- 229940127234 oral contraceptive Drugs 0.000 description 1
- 239000003539 oral contraceptive agent Substances 0.000 description 1
- 201000004535 ovarian dysfunction Diseases 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000583 progesterone congener Substances 0.000 description 1
- 229940097325 prolactin Drugs 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110007679 CN102114240B (zh) | 2011-01-14 | 2011-01-14 | 原料含有水蛭素、纤溶素的药物的用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110007679 CN102114240B (zh) | 2011-01-14 | 2011-01-14 | 原料含有水蛭素、纤溶素的药物的用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102114240A CN102114240A (zh) | 2011-07-06 |
CN102114240B true CN102114240B (zh) | 2013-07-17 |
Family
ID=44213240
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110007679 Active CN102114240B (zh) | 2011-01-14 | 2011-01-14 | 原料含有水蛭素、纤溶素的药物的用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102114240B (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1137897A (zh) * | 1995-06-09 | 1996-12-18 | 胡远华 | 动物血水蛭水解法及其水蛭水解血 |
-
2011
- 2011-01-14 CN CN 201110007679 patent/CN102114240B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1137897A (zh) * | 1995-06-09 | 1996-12-18 | 胡远华 | 动物血水蛭水解法及其水蛭水解血 |
Non-Patent Citations (3)
Title |
---|
侯安会,等.水蛭的临床运用和实验研究概要.《黑龙江中医药》.1994,(第4期), * |
欧兴长.水蛭活血有效成分研究概况.《中国中医基础医学杂志》.1997,第4卷(第2期), * |
王蒙萌,等.水蛭的化学成分及药理作用.《黑龙江中医药》.2008,(第2期), * |
Also Published As
Publication number | Publication date |
---|---|
CN102114240A (zh) | 2011-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103585378B (zh) | 一种治疗女性不孕症的中药组合物及其制备方法 | |
CN105031559B (zh) | 一种治疗由多囊卵巢综合征引起不孕症的中药 | |
CN101342353A (zh) | 治疗不孕症的中药制剂及其制备方法 | |
CN102302659B (zh) | 用于肾阳虚痰阻型多囊卵巢综合征的中药组合物 | |
CN109528980A (zh) | 一种用于治疗卵巢储备功能下降疾病的中药组合物及其制药应用 | |
CN104523889B (zh) | 一种治疗滑胎的中药制剂及其制备方法 | |
CN108653680A (zh) | 一种治疗寒凝血瘀型痛经的肚脐贴 | |
CN102114240B (zh) | 原料含有水蛭素、纤溶素的药物的用途 | |
CN102048913B (zh) | 一种治疗更年期综合症的中药制剂及其制备方法 | |
CN109966407B (zh) | 培元养肝丸 | |
CN101332282A (zh) | 一种治疗肾虚阴冷所致妇科疾病的中药组合物及制备方法 | |
CN102125671B (zh) | 一种治疗肾虚阴冷所致妇科疾病的中药组合物及制备方法 | |
CN103479783A (zh) | 一种治疗更年期抑郁症的中药组合物及其应用 | |
CN103071018A (zh) | 治疗早期习惯性流产的中药制剂 | |
CN104173896A (zh) | 一种治疗闭经症的中药制剂 | |
CN108635483A (zh) | 一种治疗卵巢功能不全的中药方剂 | |
CN106334063B (zh) | 一种治疗围绝经期综合征的鹿茸粉 | |
CN107007652A (zh) | 康复新液联合中药在制备治疗不孕症的药物中的用途 | |
CN105560668A (zh) | 一种治疗免疫性不孕的药物组合物 | |
CN106237027B (zh) | 一种治疗妇科疾病的药物组合物及其制备方法 | |
CN104857115A (zh) | 一种治疗血寒凝滞型闭经的中药组合物及其制备方法 | |
CN105311396A (zh) | 一种治疗子宫内膜薄致月经过少的中药制剂 | |
CN105943658B (zh) | 一种治疗多囊卵巢综合征的药物及其制法与用途 | |
CN105641057A (zh) | 一种治疗脾不统血型原发性肾小球性血尿的药物组合物 | |
CN104258294A (zh) | 壮骨粉 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: Cao Jia Dian 400802 Chongqing city Wansheng District East Qingxi Bridge Applicant after: CHONGQING DUOPUTAI PHARMACEUTICAL Co.,Ltd. Address before: Cao Jia Dian 400802 Chongqing city Wansheng District East Qingxi Bridge Applicant before: CHONGQING SHIZHENGE PUSHENG PHARMACEUTICAL Co.,Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: CHONGQING SHIZHEN'GE PUSHENG PHARMACEUTICAL CO., LTD. TO: CHONGQING DUOPUTAI PHARMACEUTICAL CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: Cao Jia Dian 400800 Chongqing city Wansheng District East Qingxi Bridge Patentee after: CHONGQING DUOPUTAI PHARMACEUTICAL Co.,Ltd. Address before: Cao Jia Dian 400802 Chongqing city Wansheng District East Qingxi Bridge Patentee before: Chongqing Duoputai Pharmaceutical Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240116 Address after: No. 303-7, Qingxi Bridge, Donglin Street, Wansheng Economic Development Zone, Qijiang District, Chongqing, 400800 Patentee after: Chongqing Duoputai Pharmaceutical Technology Co.,Ltd. Address before: 400800 Donglin Qingxi bridge in Wansheng District, Chongqing Patentee before: CHONGQING DUOPUTAI PHARMACEUTICAL Co.,Ltd. |